Patents by Inventor Deirdre Mary Hickey

Deirdre Mary Hickey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Piperazinediones as Oxytocin Receptor Antagonists
    Publication number: 20070254888
    Abstract: Compounds of formula (I) wherein R1 is 2-indanyl, R2 is 1-methylpropyl, R3 is a group selected from 2,6-dimethyl-3-pyridyl or 4,6-dimethyl-3-pyridyl, R4 represents methyl and R5 represents hydrogen or methyl or, R4 and R5 together with the nitrogen atom to which they are attached represent morpholino and pharmaceutically acceptable derivatives thereof are described, as are processes for their preparation, pharmaceutical compositions containing them and their use in medicine, particularly their use as oxytocin antagonists.
    Type: Application
    Filed: June 21, 2005
    Publication date: November 1, 2007
    Applicant: GLAXO GROUP LIMITED
    Inventors: Alan Borthwick, Deirdre Mary Hickey, John Liddle, Andrew Mason
  • Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
    Publication number: 20060040371
    Abstract: The enzyme Lp-PLA2 in purified form, an isolated nucleic acid molecule encoding Lp-PLA2, the use of an inhibitor of the enzyme Lp-PLA2 in therapy and a method of screening compounds to identify those compounds which inhibit the enzyme.
    Type: Application
    Filed: May 31, 2005
    Publication date: February 23, 2006
    Inventors: Colin MacPhee, David Tew, Donald Southan, Deirdre Mary Hickey, Israel Gloger, Geoffrey Lawrence, Simon John Rice
  • Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
    Publication number: 20050260731
    Abstract: The enzyme Lp-PLA2 in purified form, an isolated nucleic acid molecule encoding Lp-PLA2, the use of an inhibitor of the enzyme Lp-PLA2 in therapy and a method of screening compounds to identify those compounds which inhibit the enzyme.
    Type: Application
    Filed: April 18, 2005
    Publication date: November 24, 2005
    Inventors: Colin MacPhee, David Tew, Christopher Southan, Deirdre Mary Hickey, Israel Gloger, Geoffrey Mark Lawrence, Simon Rice